Ligan, Ronald N.
HRN: 26-78-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2025
CEFTRIAXONE 1G (VIAL)
03/08/2025
03/15/2025
IV
1g
Q12
Lacerated Wound Frontal Area Right, Lacerated Wound Frontal To Nasal Bridge Area, Avulsed Wound Left Nostril
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes